Ecstasy, the amphetamine-like drug made popular by ``raves'' and other mass dancing events, can severely deplete levels of a brain chemical linked with mood, researchers said on Monday.
Published:
24 July 2000 y., Monday
This could explain why users report they feel depressed as they come down off a high, the Canadian team of researchers said.
They said a 26-year-old man who had died of a drug overdose had very low levels of serotonin in his brain. Serotonin is an important neurotransmitter or message-carrying chemical linked with mood, appetite, sleep and emotions.
The man had been using Ecstasy for nine years, and in the last months of his life had also started using cocaine and heroin, the researchers wrote in the journal Neurology.
Ecstasy, known chemically as methylenedioxymethamphetamine, or MDMA, is related to the hallucinogen mescaline and the stimulant amphetamine. It causes brain cells known as neurons to release serotonin. Ecstasy users say the drug makes them feel intimacy with other people and more aware of their emotions.
Šaltinis:
Yahoo! News
Copying, publishing, announcing any information from the News.lt portal without written permission of News.lt editorial office is prohibited.
The most popular articles
The only physician in her village of Tsoniarisi, Mzevinar Bolkvadze sees patients all day in a newly built and equipped ambulatory.
more »
As of 7 September 2009, 48 of the 53 Member States in the WHO European Region had reported over 49 000 laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection.
more »
China's food and drug administration say clinical trials of a vaccine against the H1N1 flu strain have been successful.
more »
As of 31 August 2009, 48 of the 53 Member States in the WHO European Region had reported laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection.
more »
The European Union Health Security Committee and the Early Warning and Response authorities adopted a policy statement proposed by the European Commission which outlines a shared European approach towards identifying target and priority groups for A H1N1 vaccination.
more »
As of 20 August 2009, 47 of the 53 Member States in the WHO European Region had reported over 42 000 laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection.
more »
About 1000 participants, mostly from North America, debated solutions to the obesity epidemic in the United States (US) at the Weight of the Nation conference, organized in Washington, USA, by the US Centers for Disease Control.
more »
The European Union Health Security Committee and the Early Warning and Response authorities (HSC/EWRS) unanimously adopted for the first time two policy statements proposed by the European Commission on public health measures for pandemic influenza A (H1N1) 2009.
more »
As of 10 August 2009, 46 of the 53 countries in the WHO European Region had reported over 33 000 laboratory-confirmed cases of pandemic (H1N1) 2009 virus infection, including 55 fatalities in 7 countries.
more »
The U.S. company Moog Medical Devices which acquired the company the Lithuanian Viltechmeda at the beginning of the year 2009, intends to invest EUR 2M in Lithuania in the nearest future, to establish a modern services centre.
more »